After cardiac surgery, healthcare-associated infections (HAIs) are common complications associated with increased morbidity, mortality, and use of resources.

Medic Vision Imaging Solutions Ltd. recently signed agreements with three major healthcare purchasing organizations, namely Premier and Health Trust PG, to offer the SafeCT to thousands of their member hospitals and other healthcare providers at pre-negotiated special terms.

Vital Images Inc. will participate in the Image Sharing Demonstration (North Building, Hall B, booth 8140) at the annual meeting of the Radiological Society of North America (RSNA), Dec. 1-5 in Chicago.

Millar Inc. and CD Leycom announced the appointment of Millar as the exclusive U.S. distributor of CD Leycom’s clinical Inca in pressure-volume (PV) loop system and disposable clinical PV loop catheters.

GE Healthcare announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) in-house. Optison is a contrast agent that may improve the visualization of the left ventricular border ? an area of the heart that is critical to see in order to assess and diagnose certain heart diseases. As a result of the FDA’s action, GE Healthcare will provide a supply of Optison to the U.S. and European markets from its manufacturing facility in Oslo, Norway, becoming the only contrast media manufacturer to supply its own stock to the United States.